Celldex Therapeutics Price to Book Ratio 2010-2022 | CLDX
Historical price to book ratio values for Celldex Therapeutics (CLDX) over the last 10 years. The current price to book ratio for Celldex Therapeutics as of March 23, 2023 is 5.24.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Celldex Therapeutics Price/Book Ratio Historical Data |
| Date |
Stock Price |
Book Value per Share |
Price to Book Ratio |
| 2023-03-24 |
36.56 |
|
5.29 |
| 2022-12-31 |
44.57 |
$6.91 |
6.45 |
| 2022-09-30 |
28.11 |
$7.33 |
3.83 |
| 2022-06-30 |
26.96 |
$7.98 |
3.38 |
| 2022-03-31 |
34.06 |
$8.51 |
4.00 |
| 2021-12-31 |
38.64 |
$8.98 |
4.30 |
| 2021-09-30 |
53.99 |
$9.36 |
5.77 |
| 2021-06-30 |
33.44 |
$4.60 |
7.27 |
| 2021-03-31 |
20.60 |
$4.90 |
4.20 |
| 2020-12-31 |
17.52 |
$5.29 |
3.31 |
| 2020-09-30 |
14.83 |
$5.81 |
2.55 |
| 2020-06-30 |
13.00 |
$6.10 |
2.13 |
| 2020-03-31 |
1.66 |
$4.72 |
0.35 |
| 2019-12-31 |
2.23 |
$5.54 |
0.40 |
| 2019-09-30 |
2.13 |
$6.37 |
0.33 |
| 2019-06-30 |
2.68 |
$7.40 |
0.36 |
| 2019-03-31 |
4.92 |
$8.77 |
0.56 |
| 2018-12-31 |
2.97 |
$10.37 |
0.29 |
| 2018-09-30 |
6.77 |
$11.40 |
0.59 |
| 2018-06-30 |
7.55 |
$12.26 |
0.62 |
| 2018-03-31 |
34.95 |
$14.02 |
2.49 |
| 2017-12-31 |
42.60 |
$25.59 |
1.66 |
| 2017-09-30 |
42.90 |
$24.87 |
1.72 |
| 2017-06-30 |
37.05 |
$27.24 |
1.36 |
| 2017-03-31 |
54.15 |
$29.92 |
1.81 |
| 2016-12-31 |
53.10 |
$33.02 |
1.61 |
| 2016-09-30 |
60.60 |
$32.15 |
1.89 |
| 2016-06-30 |
65.85 |
$35.40 |
1.86 |
| 2016-03-31 |
56.70 |
$39.49 |
1.44 |
| 2015-12-31 |
235.20 |
$44.07 |
5.34 |
| 2015-09-30 |
158.10 |
$48.43 |
3.26 |
| 2015-06-30 |
378.30 |
$52.62 |
7.19 |
| 2015-03-31 |
418.05 |
$57.17 |
7.31 |
| 2014-12-31 |
273.75 |
$35.42 |
7.73 |
| 2014-09-30 |
194.40 |
$40.13 |
4.84 |
| 2014-06-30 |
244.80 |
$44.50 |
5.50 |
| 2014-03-31 |
265.05 |
$48.97 |
5.41 |
| 2013-12-31 |
363.15 |
$53.72 |
6.76 |
| 2013-09-30 |
531.45 |
$28.97 |
18.34 |
| 2013-06-30 |
234.15 |
$32.79 |
7.14 |
| 2013-03-31 |
173.70 |
$36.14 |
4.81 |
| 2012-12-31 |
100.65 |
$22.31 |
4.51 |
| 2012-09-30 |
94.50 |
$22.44 |
4.21 |
| 2012-06-30 |
77.63 |
$24.13 |
3.22 |
| 2012-03-31 |
76.35 |
$27.54 |
2.77 |
| 2011-12-31 |
39.00 |
$23.30 |
1.67 |
| 2011-09-30 |
34.28 |
$27.40 |
1.25 |
| 2011-06-30 |
53.25 |
$31.25 |
1.70 |
| 2011-03-31 |
60.30 |
$30.77 |
1.96 |
| 2010-12-31 |
61.80 |
$35.20 |
1.76 |
| 2010-09-30 |
60.00 |
$24.33 |
2.47 |
| 2010-06-30 |
68.40 |
$28.21 |
2.42 |
| 2010-03-31 |
92.10 |
$32.32 |
2.85 |
| 2009-12-31 |
70.05 |
$34.90 |
2.01 |
| 2009-09-30 |
82.35 |
$-2.11 |
-38.94 |
| 2009-06-30 |
117.30 |
$4.06 |
28.87 |
| 2009-03-31 |
97.65 |
$11.17 |
8.74 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$1.714B |
$0.002B |
|
CELLDEX THERAPEUTICS is an integrated biopharmaceutical company that applies its comprehensive Precision Targeted Immunotherapy Platform to generate a pipeline of candidates to treat cancer and other difficult-to-treat diseases. Celldex's immunotherapy platform includes a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulators to create novel disease-specific drug candidates.
|
